Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1999
10/13/1999CN1231193A Capsule for treating gonorrhea and preparation method
10/13/1999CN1231192A Skin-grafting ointment and preparation method
10/13/1999CN1231186A Set prescription decoction and single medicine decoction of traditional Chinese medicine
10/13/1999CN1231182A Bear gallbladder injection
10/13/1999CN1231180A Detoxifying medicine and preparation process thereof
10/13/1999CN1231179A Medicine for radical curing athlete's foot
10/13/1999CN1231177A Novel contraceptive compositions and preparation process thereof
10/13/1999CN1045536C Plaster for curing fracture
10/13/1999CN1045533C Continuous process for making a non-newtonian paste or cream like material
10/12/1999US5965611 Pharmaceutical composition for treating peripheral circulation disorders
10/12/1999US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999US5965603 Nonaqueous compositions for parenteral administration
10/12/1999US5965584 Pharmaceutical composition
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999US5965551 Method of treating alopecia
10/12/1999US5965549 Ciprofloxacin-hydrocortisone suspension
10/12/1999US5965542 Use of temperature to control the size of cationic liposome/plasmid DNA complexes
10/12/1999US5965519 Covalent polar lipid conjugates with biologically-active compounds for use in salves
10/12/1999US5965515 Coated amine functionality-containing materials
10/12/1999US5965434 Compounds contain cationic groups whose positive charge increases with decreasing ph; cationic liposomes fuse at ph's in the low end of the physiologic range; use in drug delivery systems; efficiency, less toxicity
10/12/1999US5965411 Maltose-trehalose converting enzyme, and preparation and uses thereof
10/12/1999US5965258 Drug delivery
10/12/1999US5965168 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
10/12/1999US5965167 Composition containing microspheres produced by imposing liquiflash on active agent and processing aid and coating of blend of polymers having different levels of hydrophilicity; sustained release
10/12/1999US5965166 Dry shearing a mixture of 60-95% acetaminophen and a direct compression vehicle, microcrystalline cellulose, into a stable homogenous granulate; mixing with a lubricant and compressing into a solid dose
10/12/1999US5965165 Process for the production of granules, and granules thus obtained
10/12/1999US5965164 For oral use, comprising shearlite particles (made under liquiflash conditions) of bio-affecting agent in metered dose which are flowable to be administered under gravity, and a bifunctional vessel for storage and transportation
10/12/1999US5965163 Solid dosage of drug in a matrix of a fusible material (m.p. 35-150 degrees c.) comprising a mixture of hydrophobic and hydrophilic carriers formed by controlled granulation, comminution and mechanically working the agglomerants
10/12/1999US5965162 Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
10/12/1999US5965161 Extruded multi-particulates
10/12/1999US5965160 Self-emulsifiable formulation producing an oil-in-water emulsion
10/12/1999US5965159 Etherlipid-containing multiple lipid liposomes
10/12/1999US5965158 Liposomal-polyene preliposomal powder and method for its preparation
10/12/1999US5965157 Method to provide for production of hair coloring pigments in hair follicles
10/12/1999US5965156 Amphotericin B liposome preparation
10/12/1999US5965155 Transdermal therapeutic system with pentylene tetrazol as active substance
10/12/1999US5965154 Adhesive matrix type transdermal patch and method of manufacturing same
10/12/1999US5965152 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/12/1999US5965125 Hybrid matrix implants and explants
10/12/1999US5965121 Compounds and compositions for delivering active agents
10/12/1999US5965110 Plaque adsorbent oral composition and method
10/12/1999US5965070 Fractionated agaroid compositions, their preparation, and use
10/12/1999US5964804 Close vascularization implant material
10/12/1999US5964745 Inplatable infection shield; drug delivery
10/12/1999US5964261 Implantation assembly
10/12/1999US5964224 Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor
10/12/1999US5964043 Freeze-drying process and apparatus
10/12/1999CA2172807C Tastemasked liquid pharmaceutical delivery system
10/12/1999CA2168732C Gelatin capsules containing a highly concentrated acetaminophen solution
10/12/1999CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses
10/12/1999CA2027864C Formulations for sustained release dressings and their use
10/10/1999CA2273546A1 Nefazodone dosage form
10/07/1999WO1999049909A2 Revascularization apparatus having coaxial channeling and injecting means
10/07/1999WO1999049908A1 Temperature controlled solute delivery system
10/07/1999WO1999049897A1 Hemoglobin-polysaccharide conjugates
10/07/1999WO1999049896A1 A drug composition containing sodium pravastatin
10/07/1999WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999WO1999049887A1 Use of protease inhibitors for treating skin wounds
10/07/1999WO1999049886A1 Compositions containing bactericides and digestive enzymes compositions
10/07/1999WO1999049875A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
10/07/1999WO1999049869A1 Methods to potentiate intravenous estramustine phosphate
10/07/1999WO1999049868A1 Sustained-release composition containing cefaclor
10/07/1999WO1999049867A1 Novel galenic formulations of meloxicam for oral administration
10/07/1999WO1999049863A1 Sustained release preparations
10/07/1999WO1999049857A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999WO1999049853A1 Therapeutic system which can be moisture-activated
10/07/1999WO1999049852A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
10/07/1999WO1999049851A1 Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
10/07/1999WO1999049850A1 Composition comprising a liquid absorbed on a support based on precipitate silica
10/07/1999WO1999049849A1 Liposomal bupivacaine compositions and methods of preparation
10/07/1999WO1999049848A1 Anticancer compositions
10/07/1999WO1999049846A2 Compositions containing microparticles of water-insoluble substances and method for their preparation
10/07/1999WO1999049845A1 Peroral active agent suspension
10/07/1999WO1999049844A2 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
10/07/1999WO1999049843A1 Solid, quick dissolving cetirizine formulations
10/07/1999WO1999049842A1 Fizzy formulations
10/07/1999WO1999049835A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999WO1999049833A1 Covering sheet for skin and hair
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999049716A2 Method for producing liposomal formulations of active agents by high-pressure homogenisation
10/07/1999WO1999043269A3 Veterinary delivery device and method
10/07/1999WO1999034919A3 Device for coating granules to be administered orally
10/07/1999WO1999033453A3 R-procyclidine for treating urinary incontinence
10/07/1999WO1999018930A3 Pharmaceutical preparations
10/07/1999DE19901270A1 Production of beta-1,6-branched beta-1,3-glucan useful as skin anti-aging, depigmenting and healing agent
10/07/1999DE19835823A1 Antibiotic composition useful for preparing stable aqueous suspensions
10/07/1999DE19815327A1 Drug-containing chewable pastille production, using specific additives and dissolution conditions to give homogeneous drug distribution and consistent release
10/07/1999DE19814739A1 Solubilizing agents useful in pharmaceutical, cosmetic and food compositions
10/07/1999DE19814730A1 Pharmaceutical and cosmetic compositions with matrix containing N-vinyllactam or N-vinylamine based copolymer
10/07/1999DE19814513A1 Use of aqueous polymer-containing compositions for subcutaneous or intramuscular drug delivery formulations
10/07/1999DE19814392A1 Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff Calcium-containing effervescent tablet with an antihistamine as active ingredient
10/07/1999DE19814358A1 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn Use of alkyl hydrogen for the treatment of psoriasis, psoriatic arthritis, atopic dermatitis, and Crohn's disease
10/07/1999DE19814257A1 Brauseformulierungen Effervescent formulations
10/07/1999DE19814256A1 Feste, schnellzerfallende Cetirizin-Formulierungen Solid rapidly disintegrating cetirizine formulations
10/07/1999CA2326774A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999CA2326603A1 A drug composition containing sodium pravastatin
10/07/1999CA2326438A1 Use of protease inhibitors for treating skin wounds
10/07/1999CA2325858A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999CA2324477A1 Use of active p40 conjugates for nasal delivery
10/07/1999CA2295049A1 Methods to potentiate intravenous estramustine phosphate
1 ... 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 ... 2991